DiaMedica Therapeutics Inc.

DMAC

DiaMedica Therapeutics Inc.

DMAC

Insider Sentiment (TTM):

Last Purchase:2025-11-25Last Sale:2022-12-02Shares Purchased (TTM):73,099Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:11,602,069Shares Outstanding:53,793,490Institutional Ownership Pct.:21.57%

Earnings Market Reaction:

Filing Date:2026-08-10Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Cash And Cash Equivalents At Carrying Value	5	5	16	3	4	3	3	4	14	2	5	2
Assets Current
Assets Current	44	52	61	56	31	37	45	51	55	47	54	48
Marketable Securities Current	38	46	44	52	26	34	41	46	40	44	48	44
Prepaid Expense And Other Assets Current	1	1	0	0	1	1	0	0	1	1	0	1
Accounts Receivable Net Current	0	0	0	0	0	0	0	0	0	0	0	0
Deposits Assets Current	-	-	-	0	0	0	-	-	-	-	-	-
Marketable Securities Noncurrent	-	-	-	-	-	1	-	-	-	-	-	10
Deferred Costs	0	0	0	0	-	-	0	-	-	-	-	-
Assets Noncurrent
Assets Noncurrent	1	1	1	1	0	1	2	2	2	2	0	10
Operating Lease Right Of Use Asset	0	0	0	0	0	0	0	0	0	0	0	0
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Deposits Assets Noncurrent	-	-	0	0	0	0	1	1	1	1	0	-
Assets	45	53	61	57	31	39	46	53	57	49	54	58
Accounts Payable Current	3	3	1	2	1	2	1	1	1	1	1	1
Liabilities Current
Accrued Liabilities Current	4	2	4	3	3	3	4	3	2	2	2	1
Liabilities Current	7	6	5	5	4	5	5	4	3	3	3	2
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Finance Lease Liability Current	-	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Liability Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities Noncurrent
Liabilities Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Finance Lease Liability Noncurrent	-	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	231	230	229	216	183	182	181	180	179	167	167	166
Stockholders Equity
Stockholders Equity	38	47	56	52	27	34	41	48	53	46	51	56
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	0	0	-0	0	0	0	-0	-0	0	-0
Retained Earnings Accumulated Deficit	-193	-183	-173	-164	-155	-148	-140	-132	-126	-121	-116	-110
Liabilities And Stockholders Equity	45	53	61	57	31	39	46	53	57	49	54	58
Common Stock No Par Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Issued	54	54	54	52	43	43	43	43	43	38	38	38
Shares Outstanding	54	54	54	52	43	43	43	43	43	38	38	38

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-8.13%	0.46%	3.30%	-	-	-	-	-	-	-	-	-
2025	4.02%	-5.53%	3.52%	17.62%	35.44%	35.25%	39.14%	25.67%	27.42%	-4.67%	-10.99%	-11.90%
2024	-16.43%	-14.99%	4.90%	20.92%	28.62%	35.08%	26.76%	30.52%	35.21%	-42.07%	-38.90%	-30.88%
2023	-	-	-	17.25%	-20.42%	-10.56%	24.79%	22.22%	28.21%	-13.83%	10.64%	-9.22%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	6.72	9.11	11.81	10.67	7.55	8.02	8.28	11.81	17.82	18.14	19.27	22.07
Quick Ratio	6.63	8.98	11.72	10.59	7.39	7.88	8.23	11.75	17.63	17.93	19.12	21.56
Working Capital	37.72M	46.62M	55.50M	50.96M	26.96M	32.76M	39.22M	46.47M	51.93M	44.87M	50.89M	45.72M
Leverage & Debt
Debt to Equity	0.17	0.12	0.09	0.11	0.16	0.14	0.14	0.10	0.06	0.06	0.06	0.05
Debt Ratio	0.15	0.11	0.09	0.10	0.14	0.13	0.12	0.09	0.06	0.06	0.06	0.04
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Receivables Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Free Cash Flow Per Share TTM	-0.55	-0.58	-0.62	-0.42	-0.43	-0.53	-0.55	-0.46	-0.52	-0.54	-0.58	-0.47
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	26.91%	30.00%	34.05%	47.09%	48.63%	40.19%	26.12%	20.78%	20.19%	24.74%	41.72%	36.44%
EPS Growth (1Y)	1.16%	3.54%	15.28%	26.70%	31.71%	24.20%	1.66%	7.21%	-13.77%	-13.08%	15.07%	-4.93%
Valuation Metrics
P/E TTM	-10.11	-10.38	-11.41	-10.68	-5.66	-6.01	-8.98	-8.25	-5.64	-5.46	-4.77	-5.45
P/B TTM	9.90	7.71	6.66	6.60	6.17	4.78	5.39	3.73	2.10	2.27	1.81	1.76
Market Cap	379.42M	364.18M	373.97M	340.96M	167.53M	162.38M	219.40M	179.13M	112.30M	105.14M	92.49M	97.91M
Enterprise Value	374.29M	359.33M	358.33M	337.65M	163.45M	159.81M	216.40M	175.02M	98.27M	103.05M	87.95M	95.68M
Calculated Values
Free Cash Flow TTM	-29.63M	-31.04M	-29.11M	-20.62M	-18.54M	-22.60M	-22.10M	-19.48M	-19.80M	-20.32M	-18.75M	-17.74M
Net Debt	-5.13M	-4.86M	-15.63M	-3.31M	-4.09M	-2.57M	-3.00M	-4.11M	-14.04M	-2.09M	-4.54M	-2.23M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-11-25Purchase

Owner: Trill, Ab, Stahlberg Jan

Title: -

Shares: 73,099

Price/Share: $8.57

Value: $626,458.43

Shares Owned: 8,825,742

Relationship: TenPercentOwner

Ownership: Indirect

2025-08-20Purchase

Owner: Stahlberg, Jan, Trill Ab

Title: -

Shares: 71,107

Price/Share: $5.86

Value: $416,687.02

Shares Owned: 7,207,820

Relationship: TenPercentOwner

Ownership: Indirect

2025-07-23Purchase

Owner: Jacinto, Richard Ii

Title: -

Shares: 400,000

Price/Share: $3.50

Value: $1,400,000.00

Shares Owned: 4,958,823

Relationship: TenPercentOwner

Ownership: Indirect

2025-07-23Purchase

Owner: Von, Koch Thomas, Tomente…

Title: -

Shares: 2,857,142

Price/Share: $3.50

Value: $9,999,997.00

Shares Owned: 8,383,577

Relationship: TenPercentOwner

Ownership: Indirect

2025-07-23Purchase

Owner: Stahlberg, Jan, Trill Ab

Title: -

Shares: 1,542,857

Price/Share: $3.50

Value: $5,399,999.50

Shares Owned: 6,764,465

Relationship: TenPercentOwner

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-11-25	Trill, Ab, Stahlberg Jan	TenPercentOwner	-	Indirect	Purchase	73,099	8.57	$626,458.43	8,825,742	4
2025-08-20	Stahlberg, Jan, Trill Ab	TenPercentOwner	-	Indirect	Purchase	71,107	5.86	$416,687.02	7,207,820	4
2025-07-23	Jacinto, Richard Ii	TenPercentOwner	-	Indirect	Purchase	400,000	3.50	$1,400,000.00	4,958,823	4
2025-07-23	Von, Koch Thomas, Tomente…	TenPercentOwner	-	Indirect	Purchase	2,857,142	3.50	$9,999,997.00	8,383,577	4
2025-07-23	Stahlberg, Jan, Trill Ab	TenPercentOwner	-	Indirect	Purchase	1,542,857	3.50	$5,399,999.50	6,764,465	4
2024-06-28	Stahlberg, Jan, Trill Ab	TenPercentOwner	-	Indirect	Purchase	1,200,000	2.50	$3,000,000.00	5,221,608	4
2024-06-28	Tomenterprise, Private Ab…	TenPercentOwner	-	Indirect	Purchase	1,200,000	2.50	$3,000,000.00	5,526,435	4
2023-11-16	Wambeke, David J.	Officer	Chief Business Officer	Direct	Purchase	20,000	2.46	$49,200.00	527,114	4
2023-06-23	Wambeke, David J.	Officer	Chief Business Officer	Direct	Purchase	38,364	3.91	$150,003.24	507,114	4
2023-06-23	Pauls, Dietrich John	Director,Officer	President and CEO	Direct	Purchase	12,787	3.91	$49,997.17	68,591	4
2023-06-23	Giuffre, Randall Michael	Director	-	Direct	Purchase	65,000	3.91	$254,150.00	360,355	4
2023-06-23	Kellen, Scott	Officer	CFO and Secretary	Direct	Purchase	10,000	3.91	$39,100.00	32,290	4
2023-06-23	Pilnik, Richard D.	Director	-	Direct	Purchase	38,363	3.91	$149,999.33	248,245	4
2023-06-23	Tomeqt, Private Ab, Von K…	TenPercentOwner	-	Indirect	Purchase	1,470,588	3.40	$4,999,999.20	4,326,435	4
2023-06-23	Semba, Charles Pauling	Director	-	Direct	Purchase	12,787	3.91	$49,997.17	29,943	4
2023-04-10	Wambeke, David J.	Officer	Chief Business Officer	Direct	Purchase	468,750	1.60	$750,000.00	468,750	4
2022-12-09	Giuffre, Randall Michael	Director	-	Direct	Purchase	37,079	1.43	$53,022.97	260,225	4
2022-12-07	Giuffre, Randall Michael	Director	-	Direct	Purchase	22,574	1.40	$31,603.60	203,146	4
2022-12-05	Pilnik, Richard D.	Director	-	Direct	Purchase	35,000	1.39	$48,650.00	154,327	4
2022-12-02	Von, Koch Thomas, Tomente…	TenPercentOwner	-	Indirect	Sale	2,855,847	1.24	$3,541,250.28	0	4
2022-12-02	Von, Koch Thomas, Tomente…	TenPercentOwner	-	Indirect	Purchase	2,855,847	1.24	$3,541,250.28	2,855,847	4
2022-12-01	Giuffre, Randall Michael	Director	-	Direct	Purchase	819	1.19	$974.61	178,272	4
2022-11-30	Giuffre, Randall Michael	Director	-	Direct	Purchase	2,970	1.19	$3,534.30	131,320	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

21.57%

Inst. Shares: 11,602,069

Shares Outstanding: 53,793,490

2025-12-31

25.58%

Inst. Shares: 12,018,322

Shares Outstanding: 46,980,777

2025-09-30

25.65%

Inst. Shares: 12,731,811

Shares Outstanding: 49,630,119

2025-06-30

19.86%

Inst. Shares: 8,531,154

Shares Outstanding: 42,957,619

2025-03-31

17.30%

Inst. Shares: 7,414,122

Shares Outstanding: 42,843,938

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	11,602,069	53,793,490	21.57%
2025-12-31	12,018,322	46,980,777	25.58%
2025-09-30	12,731,811	49,630,119	25.65%
2025-06-30	8,531,154	42,957,619	19.86%
2025-03-31	7,414,122	42,843,938	17.30%
2024-12-31	6,701,314	40,404,681	16.59%
2024-09-30	5,576,753	42,751,577	13.04%
2024-06-30	4,976,310	38,068,378	13.07%
2024-03-31	4,599,089	37,958,000	12.12%
2023-12-31	3,841,874	32,566,723	11.80%
2023-09-30	4,250,021	37,949,422	11.20%
2023-06-30	3,489,039	27,312,008	12.77%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

DiaMedica Therapeutics Inc. (DMAC) — SEC Financial Statements & Analysis

DiaMedica Therapeutics Inc. (DMAC) is a pharmaceutical preparations company, incorporated in Z4. DiaMedica Therapeutics Inc. trades on Nasdaq as: DMAC. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), DiaMedica Therapeutics Inc. reported a Debt-to-Equity ratio of 0.17x, a Price-to-Book (P/B) ratio of 9.90x (TTM), at a market cap of $379.42M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.17x
P/B TTM: 9.90x
Market Cap: $379.42M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is DiaMedica Therapeutics Inc. in?

DiaMedica Therapeutics Inc. (DMAC) operates in the Pharmaceutical Preparations industry.

What is DMAC's market cap?

DiaMedica Therapeutics Inc. (DMAC) has a market capitalization of $379.42M as of 2026-06-30.

What exchange does DMAC trade on?

DiaMedica Therapeutics Inc. (DMAC) trades on the Nasdaq.

Where is DiaMedica Therapeutics Inc. incorporated?

DiaMedica Therapeutics Inc. is incorporated in Canada (Federal Level).